Share this post on:

Product Name :
Lapatinib/Pazopanib

Search keywords :
Lapatinib

drugId :
null

Target Vo:
Vascular endothelial growth factor receptor 1

Target Vo Short Name :
VEGFR1

Moa_Name:
Fibroblast growth factor receptor 3 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Uterine Cervical Neoplasms

Termination Status :
Phase 2 Clinical

China Termination Status :
Phase 2 Clinical

Highest Status:
Pending

China Highest Status:
Pending

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CXCL10/IP10 Antibody
IGF1 Receptor Antibody
CTGF Antibody: CTGF Antibody is an unconjugated, approximately 36 kDa, rabbit-derived, anti-CTGF polyclonal antibody. CTGF Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow background without labeling.

Share this post on:

Author: Betaine hydrochloride